|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Welcome to the AMS Newsletter for doctors and other healthcare professionals who have a special interest in women's health. The content covers information and resources relevant to menopause, midlife and the promotion of healthy ageing.
January 2024
Updated AMS Information Sheet: Bleeding – perimenopausal, postmenopausal and breakthrough bleeding on MHT/HRT![]() We are pleased to present an updated version of the clinician information sheet ‘Bleeding – perimenopausal, postmenopausal and breakthrough bleeding on MHT/HRT’. This information sheet provides up to date recommendations about the investigation of bleeding at the time of the menopause transition. Go to Information sheet here Dr Christina Jang - AMS Menopausal Hormone Therapy (MHT) discontinuation and shortages January 2024Australia Please note that Femoston-Conti 1/5 has been delisted from the PBS and is only available on private script from 1 December 2023. Patients who have been prescribed Femoston-Conti 1/5 before 1 December 2023 will be able to have it dispensed at the PBS listed price until 1 March 2024. We understand that the delisting is a commercial decision made by the sponsor. While private scripts prices fluctuate between pharmacies, it is currently being sold at a large pharmacy chain for $11.99.
There are a number of MHTs that are currently unavailable. Please note that the TGA has approved some unregistered products for supply under Section 19A.
The AMS Guide to MHT Doses (Australia only) provides a guideline to approximately equivalent doses of the different MHT/HRT products in Australia. New Zealand A list of patch availability is provided below.
More information can be found at here The AMS Guide to MHT Doses (New Zealand only) provides a guideline to approximately equivalent doses of the different MHT/HRT products in New Zealand. IMS World Congress on Menopause in Melbourne 2024Registrations are now open for the IMS World Congress in Melbourne this October. AMS members will have access to the IMS member registration rate. We are currently working with the IMS and the Congress organiser, BT Congress, to ensure the registration portal is established to allow for AMS members to have access to the IMS member discount and will advise when it is ready. Early bird registration closes on 26 March 2024. Health Professionals - join AMS for Members-only contentIMS Live 8 January 2024: Autonomic nervous system dysfunction throughout menopausal transition: A potential mechanism underpinning cardiovascular and cognitive alterations during female ageing January 2024 Menopause e-Consult: The Menopause Society 2024 Annual Meeting | Call for Abstracts Approach to Bone Health in the Perimenopause and Postmenopause European Menopause and Andropause Society (EMAS) Newsletter
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2024 Australasian Menopause Society Ltd. PO Box 280, Healesville, VIC 3777 Tel: +61 3 5962 6241 | Email: ams@menopause.org.au ![]() ![]() ![]() ![]() |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Health Professionals join the AMS now |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Contact us | Unsubscribe |